736.8500 9.50 (1.31%)
NSE Sep 25, 2026 11:01 AM
Volume: 136.3K
 

736.85
1.31%
Axis Direct
We expect the whole API industry to continue facing challenges due to a fall in realization as well as an increase in cost pressure. We foresee the situation to continue for the next 2-3 quarters and therefore recommend a HOLD rating on the stock with the target price of Rs 1,300/share.
Promoters pledged 5.54% of shares in last quarter. Total pledge stands at 37.11% of promoter holdings
More from Solara Active Pharma Sciences Ltd.
Recommended